Discussion on the use of taxanes for treatment of breast cancers in BRCA1 mutations carriers.

In contrast, a study in 25 Japanese women with advanced breast cancer reported that low levels of BRCA1 tended toward increased sensitivity to neoadjuvant docetaxel, but this did not reach statistical significance [16].

also in 111,027 other papers